Transferrin receptor genes
Abstract
Purified and isolated nucleic acid is provided which encodes a transferrin receptor protein of a strain of Haemophilus or a fragment or an analog of the transferrin receptor protein. The nucleic acid sequence may be used to produce peptides free of contaminants derived from bacteria normally containing the Tbp1 or Tbp2 proteins for purposes of diagnostics and medical treatment. Furthermore, the nucleic acid molecule may be used in the diagnosis of infection. Also provided are recombinant Tbp1 or Tbp2 and methods for purification of the same. Live vectors expressing epitopes of transferrin receptor protein for vaccination are provided.
Claims
exact text as granted — not AI-modifiedWhat we claim is:
1. A method for inducing protection against disease caused by a strain of Haemophilus influenzae , which comprises administering to a susceptible host an effective amount of an immunogenic composition comprising:
an immunogenic C-terminal truncated transferrin receptor binding protein 2 (Tbp2) of a strain of Haemophilus influenzae which is one of the C-terminal truncated proteins shown in FIG. 31 and having SEQ ID NO: 149, 150, 152, 153, 154 or 156, and a pharmaceutically-acceptable carrier therefor, said C-terminally truncated Tbp2 protein producing an immune response when administered to a host.Join the waitlist — get patent alerts
Track US6361779B1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.